奥美拉唑联合甲硝唑及阿莫西林治疗消化性溃疡的疗效观察
2020-12-23尹兆钰
尹兆钰


【摘要】 目的 觀察奥美拉唑联合甲硝唑及阿莫西林治疗消化性溃疡的疗效。方法 70例消化性溃疡患者, 以随机数字表法分为观察组与对照组, 各35例。对照组给予雷尼替丁联合甲硝唑、阿莫西林治疗, 观察组给予奥美拉唑联合甲硝唑、阿莫西林治疗。对比两组疗效、幽门螺杆菌(Hp)转阴率、治疗前后炎症因子水平、临床症状评分、不良反应发生情况。结果 观察组治疗总有效率97.14%高于对照组的80.00%, 差异有统计学意义(P<0.05)。观察组Hp转阴率为80.00%(28/35), 高于对照组的57.14%(20/35), 差异有统计学意义(χ2=4.242, P<0.05)。治疗后, 两组血清C反应蛋白(CRP)、白介素-6(IL-6)、白介素-1(IL-1)水平均降低且观察组低于对照组, 差异有统计学意义(P<0.05)。治疗后, 两组临床症状评分均降低且观察组(0.93±0.16)分低于对照组的(1.75±0.21)分, 差异有统计学意义(P<0.05)。两组不良反应发生率对比, 差异无统计学意义(χ2=0.348, P>0.05)。结论 奥美拉唑联合甲硝唑及阿莫西林治疗消化性溃疡疗效好, 能进一步缓解炎症等临床症状, 促使Hp转阴, 不增加不良反应, 值得应用。
【关键词】 奥美拉唑;阿莫西林;甲硝唑;消化性溃疡;炎症反应
DOI:10.14163/j.cnki.11-5547/r.2020.32.040
【Abstract】 Objective To observe the efficacy of omeprazole combined with metronidazole and amoxicillin in the treatment of peptic ulcer. Methods A total of 70 patients with peptic ulcer were divided into observation group and control group according to random numerical table, with 35 cases in each group. The control group was treated with ranitidine combined with metronidazole and amoxicillin, while the observation group was treated with omeprazole combined with metronidazole and amoxicillin. The efficacy, negative conversion rate of Helicobacter pylori (Hp), levels of inflammatory factors and clinical symptom score before and after treatment, incidence of adverse reactions were compared between the two groups. Results The total effective rate of treatment 97.14% of the observation group was higher than 80.00% of the control group, and the difference was statistically significant (P<0.05). The negative conversion rate of Hp of the observation group was 80.00%(28/35), which was higher than 57.14%(20/35) of the control group, and the difference was statistically significant (χ2=4.242, P<0.05). After treatment, the levels of serum C-reactive protein (CRP), interleukin-6 (IL-6), interleukin-1 (IL-1) of the two groups were lower than those before treatment, and the observation group was lower than the control group, and the difference was statistically significant (P<0.05). After treatment, the clinical symptom score of the two groups were lower than those before treatment, and the observation group (0.93±0.16) points was lower than (1.75±0.21) points of the control group, and the difference was statistically significant (P<0.05). There was no statistically significant difference in incidence of adverse reactions between the two groups (χ2=0.348, P>0.05). Conclusion Omeprazole combined with metronidazole and amoxicillin is effective in the treatment of peptic ulcer. It can further alleviate clinical symptoms such as inflammation, promote negative conversion of Hp, without increase of adverse reactions. It is worthy of application.
【Key words】 Omeprazole; Amoxicillin; Metronidazole; Peptic ulcer; Inflammatory reaction
消化性潰疡主要病因为胃酸分泌改变、胃黏膜保护作用变弱、幽门螺杆菌(helicobacter pylori, Hp)感染, 上腹疼痛, 伴有反胃、呕吐、恶心等胃肠道反应是该病临床主要症状;该病病程较长, 病情缠绵不愈, 若不能给予及时有效治疗, 病情逐渐加重, 进一步引起消化道梗阻、出血、穿孔, 甚至对患者生命安全构成威胁[1]。消化性溃疡治疗难度较高, 既往研究发现Hp持续感染、酗酒、吸烟、非甾体抗炎药使用是引起持续性溃疡的潜在原因, 尽快纠正Hp是治疗该病的重要突破口[2]。近年来不断有联合用药在消化性溃疡中的疗效研究, 以三联药物研究较多, 其中奥美拉唑、甲硝唑、阿莫西林的疗效被广泛认可, 本研究进一步分析三药联合应用对Hp转阴、炎症及溃疡面愈合的影响, 报告研究结果如下。……
